We are currently looking for people to participate in a clinical study of an investigational medication that may help to control the progression of Alzheimer’s disease. You may be eligible if you:
Participants in clinical studies can play a more active role in their own healthcare, gain access to potential new treatments before they are widely available, and help others by contributing to medical research.
The study will require 33 visits to the clinic over a period of approximately 102 weeks.
Travel expenses or transport will be provided.
For further information, please call 416 603 5910 or email
Please note communication via email is not secure, therefore please do not communicate personal sensitive information via email.
Investigator: Dr. Carmela Tartaglia
The aim of this study is to compare cognitive function, behavioural symptoms, caregiver burden and brain structure and function between patients who engage in an outpatient aerobic activity program for 6 months and those that do not. Understanding the effects of aerobic activity in patients with Alzheimer's disease may help provide better care to patients with Alzheimer's disease.
Participation would involve coming in for 3hours per week for 6 months.
You will be reimbursed for transportation and parking expenses.
For further information, please contact Dr. Carmela Tartaglia at 416 603 5483.